Dear friend: Happy April!
Power of Love’s “Safe Park” program provides a safe and fun environment for children living in slum neighborhoods to play, learn, and interact with peers. More than 700 children are enrolled. They enjoy playing Zambian games and learning through workshops led by older children and health educators.
Power of Love's micro loans program is committed to improving the lives of women living in resource poor communities.
Is malaria a problem? Malaria continues to be a deadly disease for children and vulnerable adults in Sub-Saharan Africa. In 2022, malaria claimed 608,000 lives globally (6% higher than pre-COVID), with Sub-Saharan Africa accounting for 94% of malaria cases and deaths.
“Safe Park”, is a community outreach program that promotes the physical/mental development, and healing of children by utilizing research and evidence-based interventions implemented by health workers trained in trauma management. This program is open to all children from the community and its goal is to assess children’s behavior and foster learning through educational games and workshops.
We are excited to share some incredible news about HIV prevention. As many of you know, with HIV, effective treatment is key to prevention.
Dear Power of Love Friend: Alka, Summer is here. Yay!
As we celebrate the 20th anniversary of our launch, we are thankful for your unwavering support over the last two decades. Milestones often allow us to pause and take stock. We are sharing some of our learnings with you. We hope you find them valuable. Today we begin with where we work and why we do what we do.
Power of Love's micro loans program is committed to improving the lives of women living in resource poor communities.
We have learned that providing only HIV medications to children living with HIV is not enough to ensure that children beat back HIV, stay healthy, and attend school.
In October 2022, we had shared information about the approval and launch of a malaria vaccine by the WHO. Recently we received exciting news; the new malaria vaccine is overdelivering on its efficacy.
